The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objective: To compare the efficacy of desloratadine 5mg (Denosin®) and levocetirizine 5mg
(Xyzal®) once daily in the treatment of patients with CIU over 6 weeks.
Trial design: Randomized, Double-Blind, Active-Controlled, Parallel-Group Study.
Primary end point: To evaluate the change in average AM/PM reflective pruritus score from
baseline recorded in the subjects' diaries during the first two weeks of the treatment.
Secondary Objectives: To assess the efficacy and safety of desloratadine 5mg (Denosin®) and
levocetirizine 5mg (Xyzal®) once daily in the treatment of subjects with CIU over 6 weeks.